AGENT FOR TREATING asthenic syndrome in multiple sclerosis patients

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to medicine, namely neurology, and is applicable for treating asthenic syndrome in the patients suffering multiple sclerosis. The agent contains mixed infusions of ginseng root of a true, schizandra seeds Chinese, Japanese angelica tree roots, devil's-club roots, snowdone rose roots, extracts of spiny eleuterococcus roots, Rhaponticum carthamoides roots and pantocrine taken in certain proportions.;EFFECT: agent show adaptogenic, polyglandular, including positive gonadotropic, tonic, bracing, immunomodulatory, metabolism-corrective, reparation and regeneration enhancing action; does not cause complications accompanying the long-time treatment, has no restrictions in the wide spectrum of neurologic and somatic diseases.;2 ex, 1 tbl